Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

PHASE4CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Hypertension
Interventions
DRUG

Olmesartan medoxomil

DRUG

Hydroclorothiazide

DRUG

Benazepril

DRUG

Amlodipine

Trial Locations (20)

27103

Piedmont Medical Research Associates, Winston-Salem

28211

Internal Medicine Associates of Charlotte, Charlotte

33134

Clinical Research of South Florida, Coral Gables

33142

SFBC International, Miami

33308

The Greater Fort Lauderdale Heart Group Research, Fort Lauderdale

33321

CLIRECO, Inc., Tamarac

36693

Mobile

37920

Volunteer Research Group, University of Tennessee Med. Ctr., Knoxville

45319

The Lindner Clinical Trial Center, Cincinnati

46260

Midwest Institute for Clinical Research, Indianapolis

67207

Heartland Research Associates, Wichita

75006

Punzi Medical Center, Carrollton

90057

National Research Institute, Los Angeles

90806

Memorial Research Medical Center, Long Beach

91361

Westlake Medical Center, Westlake Village

92705

Apex Research Institute, Santa Ana

92780

Orange County Research Center, Tustin

95661

Clinical Trials Research, Roseville

04210

Androscoggin Cardiology Research, Auburn

02886

Omega Medical Research, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY